Ask a clinical question and tap into Healio AI's knowledge base. Key takeaways: The impact of early disease is prompting more aggressive therapies. BTK inhibitors may offer more targeted options for progressive forms of MS. Integrated care enables closer monitoring and faster responses. Advances in diagnostics and disease-modifying therapies have significantly expanded treatment options for MS over the past 2 decades.
Robert Herpen
Verified
So tired of the pendulum swings between perpetually aggrieved and unreasonable confidence.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Robert
Contact Robert, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack